See more : Fincantieri S.p.A. (FCT.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Quantum-Si incorporated (QSIAW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quantum-Si incorporated, a leading company in the Biotechnology industry within the Healthcare sector.
- Dialight plc (DIA.L) Income Statement Analysis – Financial Results
- Bausch Health Companies Inc. (BHC) Income Statement Analysis – Financial Results
- Athabasca Minerals Inc. (ABCAF) Income Statement Analysis – Financial Results
- East Stone Acquisition Corporation (ESSCU) Income Statement Analysis – Financial Results
- Bemobi Mobile Tech S.A. (BMOB3.SA) Income Statement Analysis – Financial Results
Quantum-Si incorporated (QSIAW)
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.08M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 594.00K | 2.58M | 1.04M | 894.00K | 0.00 |
| Gross Profit | 488.00K | -2.58M | -1.04M | -894.00K | 0.00 |
| Gross Profit Ratio | 45.10% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 67.03M | 72.06M | 46.58M | 27.56M | 28.10M |
| General & Administrative | 42.81M | 42.29M | 46.38M | 7.98M | 7.88M |
| Selling & Marketing | 400.00K | 7.00K | 3.96M | 1.15M | 634.00K |
| SG&A | 44.63M | 42.30M | 50.33M | 9.14M | 8.52M |
| Other Expenses | 0.00 | -20.15M | -5.00M | -10.00K | 5.00K |
| Operating Expenses | 111.66M | 114.36M | 96.91M | 36.69M | 36.62M |
| Cost & Expenses | 112.25M | 114.36M | 96.91M | 36.69M | 36.62M |
| Interest Income | 0.00 | 0.00 | 2.54M | 88.00K | 823.00K |
| Interest Expense | 0.00 | 0.00 | 5.00K | 9.00K | 0.00 |
| Depreciation & Amortization | 4.16M | 2.58M | 1.04M | 894.00K | 780.00K |
| EBITDA | -91.80M | -129.86M | -95.87M | -35.80M | -35.84M |
| EBITDA Ratio | -8,484.66% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -111.17M | -123.84M | -96.91M | -36.69M | -36.62M |
| Operating Income Ratio | -10,274.58% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 15.21M | -8.60M | 1.92M | 78.00K | 828.00K |
| Income Before Tax | -95.96M | -132.44M | -94.99M | -36.61M | -35.79M |
| Income Before Tax Ratio | -8,868.76% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 8.60M | -6.04M | -1.00K | 5.00K |
| Net Income | -95.96M | -141.04M | -88.95M | -36.61M | -35.80M |
| Net Income Ratio | -8,868.76% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.68 | -1.01 | -1.12 | -6.81 | -0.26 |
| EPS Diluted | -0.68 | -1.01 | -1.12 | -6.81 | -0.26 |
| Weighted Avg Shares Out | 141.30M | 139.26M | 79.58M | 5.38M | 136.40M |
| Weighted Avg Shares Out (Dil) | 141.30M | 139.26M | 79.58M | 5.38M | 136.40M |
Source: https://incomestatements.info
Category: Stock Reports